Article Text

Download PDFPDF

Adverse neonatal effects of maternal labetalol treatment
  1. B N A Crooksa,
  2. S A Deshpandea,
  3. C Hallb,
  4. M P Ward Platta,
  5. D W A Milligana
  1. aNewcastle Neonatal Service Special Care Baby Unit, Royal Victoria Infirmary, Newcastle upon Tyne, bDepartment of Pharmacy
  1. Dr S A Deshpande Neonatal Unit, Royal Shrewsbury Hospitals NHS Trust, Mytton Oak Road, Shrewsbury SY3 8XQ.

Abstract

Two infants with features of severe β adrenergic blockade, pericardial effusions, and myocardial hypertrophy were born to mothers receiving long term treatment with oral labetalol for hypertension in pregnancy. Labetalol was implicated in the aetiology of these problems. Pericardial effusion and myocardial hypertrophy have not been associated with labetalol toxicity in neonates.

  • labetalol
  • hypotension
  • hypoglycaemia
View Full Text

Statistics from Altmetric.com

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.